Literature DB >> 7661743

Biochemical factors in the lens opacities. Case-control study. The Lens Opacities Case-Control Study Group.

M C Leske1, S Y Wu, L Hyman, R Sperduto, B Underwood, L T Chylack, R C Milton, S Srivastava, N Ansari.   

Abstract

OBJECTIVE: To evaluate associations with biochemical indicators of nutritional and other risk factors in the Lens Opacities Case-Control Study.
DESIGN: Case-control study. SETTING AND PARTICIPANTS: The Lens Opacities Case-Control Study determined risk factors for cortical, nuclear, and posterior subcapsular opacities among 1380 participants aged 40 to 79 years. DATA COLLECTION: Vitamin E, selenium, and biochemistry profile determinations were performed on all patients; red blood cell enzymes and amino acids were measured in systematic samples of about 25% of the Lens Opacities Case-Control Study population. OUTCOME: Laboratory test values in cases and controls were compared and expressed as odds ratios and 95% confidence intervals.
RESULTS: In polychotomous logistic regression analyses controlling for age and sex, the risk of opacities was reduced to less than one half in persons with higher levels of vitamin E (odds ratio, 0.44 for nuclear opacities), albumin-globulin ratio (odds ratio, 0.41 for mixed opacities), or iron (odds ratio, 0.43 for cortical opacities); higher uric acid levels increased risk (odds ratio, 1.74 for mixed opacities). Persons with opacities were twice as likely to have high glutathione reductase activity (with flavin adenine dinucleotide), which suggests low riboflavin status (odds ratio, 2.13). Most odds ratios for amino acids were under unity and were significantly decreased for glycine (0.36) and aspartic acid (0.31).
CONCLUSIONS: Lens opacities were associated with lower levels of riboflavin, vitamin E, iron, and protein nutritional status. Higher levels of uric acid increased risk of mixed opacities. The findings for riboflavin, vitamin E, iron, and uric acid are compatible with the dietary intake and medical history results of the Lens Opacities Case-Control Study.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7661743     DOI: 10.1001/archopht.1995.01100090039020

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  15 in total

Review 1.  Vitamin supplementation therapy in the elderly.

Authors:  J E Thurman; A D Mooradian
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

2.  The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.

Authors:  Tanya S Glaser; Lauren E Doss; Grace Shih; Divya Nigam; Robert D Sperduto; Frederick L Ferris; Elvira Agrón; Traci E Clemons; Emily Y Chew
Journal:  Ophthalmology       Date:  2015-05-09       Impact factor: 12.079

3.  Antioxidants: Basis concepts in relation to the eye.

Authors:  P Venkatesh; G Satpal; L Verma; T H Kumar; S Garg
Journal:  Indian J Clin Biochem       Date:  2001-01

4.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

5.  The concentration of light in the human lens.

Authors:  J C Merriam
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 6.  Obesity and eye diseases.

Authors:  Ning Cheung; Tien Y Wong
Journal:  Surv Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 6.048

Review 7.  Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract.

Authors:  Milan C Mathew; Ann-Margret Ervin; Jeremiah Tao; Richard M Davis
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

8.  Prospective epidemiological cohort study of reduced risk for incident cataract with vigorous physical activity and cardiorespiratory fitness during a 7-year follow-up.

Authors:  Paul T Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-11       Impact factor: 4.799

9.  The prevalence and demographic characteristics of anterior polar cataract in a hospital-based study in Korea.

Authors:  Hyojin Kim; Choun Ki Joo
Journal:  Korean J Ophthalmol       Date:  2008-06

10.  The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India.

Authors:  D C Gritz; M Srinivasan; S D Smith; U Kim; T M Lietman; J H Wilkins; B Priyadharshini; R K John; S Aravind; N V Prajna; R Duraisami Thulasiraj; J P Whitcher
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.